Access cutting-edge advanced solid tumors treatment through this clinical trial at a research site in Bethesda. Study-provided care at no cost to qualified participants.
Access advanced solid tumors specialists in Bethesda at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced solid tumors treatment provided free
This is an open label, multicenter, phase 1/2 study to assess the safety/tolerability and preliminary clinical activity of STAR0602 as a single agent administered intravenously in participants with advanced solid tumors that are antigen-rich.
Sponsor: Marengo Therapeutics, Inc.
Check if you qualify for this advanced solid tumors clinical trial in Bethesda, MD
If you're searching for advanced solid tumors treatment options in Bethesda, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Bethesda research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.